Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tessa A M Mulder

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancers|March 6, 2021
Clinical <i>CYP2D6</i> Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a ControversyTessa A M Mulder, Mirjam de With, Marzia Del Re, et al.
Frontiers in Genetics|July 26, 2021
<i>CYP3A4</i> Genotyping in Clinical Practice: Ready for Implementation?Tessa A M Mulder, Ruben A G van Eerden, Mirjam de With, et al.
Breast Cancer Research and Treatment|July 16, 2022
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trialC Louwrens Braal, Justin D Westenberg, Sanne M Buijs, et al.
Journal of Leukocyte Biology|September 20, 2024
Interferon-gamma induces epithelial reprogramming driving CXCL11-mediated T-cell migrationAlessandro Cutilli, Suze A Jansen, Francesca Paolucci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 11, 2023
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYDMirjam de With, Leni van Doorn, Demi C Maasland, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancers|March 6, 2021
Clinical <i>CYP2D6</i> Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a ControversyTessa A M Mulder, Mirjam de With, Marzia Del Re, et al.
Frontiers in Genetics|July 26, 2021
<i>CYP3A4</i> Genotyping in Clinical Practice: Ready for Implementation?Tessa A M Mulder, Ruben A G van Eerden, Mirjam de With, et al.
Breast Cancer Research and Treatment|July 16, 2022
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trialC Louwrens Braal, Justin D Westenberg, Sanne M Buijs, et al.
Journal of Leukocyte Biology|September 20, 2024
Interferon-gamma induces epithelial reprogramming driving CXCL11-mediated T-cell migrationAlessandro Cutilli, Suze A Jansen, Francesca Paolucci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 11, 2023
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYDMirjam de With, Leni van Doorn, Demi C Maasland, et al.
Pageof 1